Why Partner?

Position Your Modeling & Simulation Expertise at the Heart of MIDD Innovation & Connect With Decision-Makers Actively Seeking Your Services

The Model-Informed Drug Development Summit is the sole industry-focused event designed to cut costs and time in drug development through the improved adoption of computational models.

With an audience of 50+ highly strategic experts in pharmacometrics, clinical pharmacology, M&S, and PKPD, all actively seeking external partnerships with modeling and simulation service providers, this is your opportunity to engage directly and showcase your expertise.

As MIDD becomes critical for biopharma, it is essential for you to demonstrate that your modeling and simulation services are best-in-class, highlight your ability to bridge modeling excellence with biological insight, and prove your impact on regulatory success, clinical outcomes, and delivering effective results the first time.

Experts Need Your Help With

Bridging the gap between modeling and biological understanding to ensure models reflect real-world biology and inform better decisions.

 Supporting regulatory interactions with robust, transparent models that can withstand agency scrutiny and more!

Why Partner?

https://model-informed-drug-development-summit.com/wp-content/uploads/sites/1039/2025/07/cropped-Untitled-design.png

From our research, a growing number of companies are looking to bring all their modeling work in-house, as they want the full puzzle, not just part of it. If you offer a comprehensive MIDD package, now is the time to act before your potential client is gone for good.

https://model-informed-drug-development-summit.com/wp-content/uploads/sites/1039/2025/07/cropped-Untitled-design.png

Companies who use M&S providers often work with multiple partners at the same time on different projects. As MIDD becomes more widely used, biopharma companies are only going to need to diversify their partnerships further. Will you be on hand when this opportunity becomes available?

https://model-informed-drug-development-summit.com/wp-content/uploads/sites/1039/2025/07/cropped-Untitled-design.png

Biopharma companies are looking for partners of all sizes and have cited a preference for working with boutique service providers who offer more personalized offerings and are keen to build a long-term relationship. Are you an established provider who needs to protect their business, or an emerging player looking to make a splash as the next best thing in the M&S world?

Who Will You Meet?

Graph 2 (4)
Graph 1 (3)